Effects of ionomycin on egg activation and early development in starfish

Filip Vasilev1, Jong T Chun, Giovanni Gragnaniello

  • 1Laboratory of Cellular and Developmental Biology, Stazione Zoologica Anton Dohrn, Villa Comunale, Napoli, Italy.

Plos One
|June 23, 2012
PubMed

Insights

Ionomycin, used to increase intracellular calcium (Ca2+), causes harmful structural changes in starfish eggs, impairing fertilization and embryonic development. Further research is needed for its safe use in assisted reproduction.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Reproductive Biology

Background:

  • Ionomycin is a Ca(2+)-selective ionophore used to elevate intracellular Ca(2+) levels.
  • Its precise molecular actions and secondary effects on egg structure and function are not fully understood.
  • The ionophore is occasionally used for egg activation in in vitro fertilization (IVF) clinics.

Purpose of the Study:

  • To investigate the effects of ionomycin on starfish oocytes and zygotes.
  • To elucidate the molecular mechanisms and structural consequences of ionomycin exposure.
  • To assess the impact of ionomycin on egg activation and early embryonic development.

Main Methods:

  • Confocal microscopy and calcium imaging to monitor intracellular Ca(2+) levels.
  • Light and transmission electron microscopy to examine structural changes.
  • Microinjection of ionomycin to differentiate between external and internal effects.

Main Results:

  • Ionomycin exposure caused rapid intracellular Ca(2+) increase and cortical structural changes in oocytes.
  • Microinjected ionomycin did not elevate intracellular Ca(2+), suggesting external application is key.
  • Actin cytoskeleton alterations, cortical granule disruption, and impaired cortical maturation were observed.
  • Ionomycin-pretreated eggs showed reduced Ca(2+) response, failed fertilization envelope elevation, and abnormal development.

Conclusions:

  • Ionomycin induces detrimental structural changes in starfish eggs, negatively affecting activation and development.
  • The findings raise concerns about the potential risks of using ionomycin for artificial egg activation in IVF.
  • Further investigation is warranted to fully understand ionomycin's effects and ensure safety in clinical applications.